VZ
35
3
XEL
58
7
JBHT
40
5
MAC
65
3
ETR
57
8
AVY
75
4
BAX
18
-8
CNP
60
5
UAL
47
6
OI
32
2
TAP
40
3
XRAY
16
5
RF
35
4
QRVO
47
5
GPS
78
17
FCX
57
3
NSC
50
3
ADSK
44
8
KMI
44
8
APH
65
-2
VZ
35
3
XEL
58
7
JBHT
40
5
MAC
65
3
ETR
57
8
AVY
75
4
BAX
18
-8
CNP
60
5
UAL
47
6
OI
32
2
TAP
40
3
XRAY
16
5
RF
35
4
QRVO
47
5
GPS
78
17
FCX
57
3
NSC
50
3
ADSK
44
8
KMI
44
8
APH
65
-2
Financhill
Back

Cytek Biosciences Quote, Financials, Valuation and Earnings

Sell
35

CTKB
Cytek Biosciences

Last Price:
5.63
Seasonality Move:
11.72%

7 Day Trial

ALL ACCESS PASS

$ 7

Cytek Biosciences Price Quote

$5.63
-0.01 (-0.88%)
(Updated: June 1, 2024 at 6:13 AM ET)

Cytek Biosciences Key Stats

Sell
35
Cytek Biosciences (CTKB) is a Sell
Day range:
$5.57 - $5.85
52-week range:
$3.80 - $9.87
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
3.77
P/B ratio:
1.89%
Volume:
329.7K
Avg. volume:
588.7K
1-year change:
-27.78%
Market cap:
$740.4M
Revenue:
$193M
EPS:
$-0.09

How Much Does Cytek Biosciences Make?

Is Cytek Biosciences Growing As A Company?

  • What Is Cytek Biosciences's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.21%
  • What Is Cytek Biosciences's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Cytek Biosciences Stock Price Performance

  • Did Cytek Biosciences Stock Go Up Last Month?
    Cytek Biosciences share price went down by -6.16% last month
  • Did CTKB's Share Price Rise Over The Last Year?
    CTKB share price fell by -27.78% over the past 1 year

What Is Cytek Biosciences 52-Week High & Low?

Cytek Biosciences Price To Free Cash Flow

Is It Risky To Buy Cytek Biosciences?

  • How Much Debt Does Cytek Biosciences Have?
    Total long term debt quarterly is $3.4M
  • How Much Cash Does Cytek Biosciences Have?
    Cash and short term investments quarterly total is $270.1M
  • What Is Cytek Biosciences’s Book Value Per Share?
    Book value per share is 2.99

Is Cytek Biosciences Cash Flow Positive?

  • What Is CTKB Cash Flow From Operations?
    Cash flow from operations (TTM) is $6.4M
  • What Is Cytek Biosciences’s Cash Flow From Financing?
    Cash flow from financing (TTM) is -$40.2M
  • What Is Cytek Biosciences’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $69.2M

Cytek Biosciences Return On Invested Capital

  • Is Management Doing A Good Job?
    CTKB return on invested capital is -2.79%
  • What Is Cytek Biosciences Return On Assets?
    ROA measures how assets are converting to revenues and is -2.25%
  • What Is CTKB Return On Equity?
    ROE is a measure of profitability and is -2.81%

Cytek Biosciences Earnings Date & Stock Price

Cytek Biosciences Competitors

Cytek Biosciences Dividend Yield

Data Unavailable

Cytek Biosciences Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 0%
Revenue: 20.96% 2.92%

Analyst Recommendations

Buy Recommendations: 2
Hold Recommendations: 2
Sell Recommendations: 0
Price Target: 9.80
Upside from Last Price: 73.76%

Major Shareholders

  • How many CTKB shares are owned by institutional investors?
    129.5M CTKB shares are owned by institutional investors
  • How many CTKB shares are owned by insiders?
    11.5M CTKB shares are owned by insiders